| ID: | 211 | |
|---|---|---|
| Name: | Compound 211 | |
| Description: | Original numeration in publication: 8c | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C16H13N7S/c24-16(18-11-6-2-1-3-7-11)21-19-14-12-8-4-5-9-13(12)15-20-17-10-23(15)22-14/h1-10H,(H,19,22)(H2,18,21,24) |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.14 |
El-Helby, A.-G. A.; Ayyad, R. R. A.; Sakr, H. a. E.-A., K.; Ali, M. M.; Khedr, F. Design, synthesis, molecular docking, and anticancer activity of phthalazine derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2017, 350, 1700240. https://doi.org/10.1002/ardp.201700240 |
| 5.97283 |
Eq1: VEGFR-2 inhibition (Data used to train model) |